VVP
PPBT

Venture Visionary Partners’s Purple Biotech PPBT Stock Holding History

Venture Visionary Partners’s Portfolio PPBT Stock Details PPBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-111
Closed -$9.02K – 575
2024
Q2 		$9.02K Buy
111
+33
+42% +$3.83K ﹤0.01% 550
2024
Q1 		$10.4K Hold
78
– – ﹤0.01% 550
2023
Q4 		$12.1K Buy
78
+5
+7% +$1.11K ﹤0.01% 521
2023
Q3 		$17.3K Buy
73
+4
+6% +$953 ﹤0.01% 505
2023
Q2 		$19.1K Buy
69
+4
+6% +$1.44K ﹤0.01% 530
2023
Q1 		$23.4K Hold
65
– – ﹤0.01% 492
2022
Q4 		$18K Hold
65
– – ﹤0.01% 471
2022
Q3 		$26K Hold
65
– – ﹤0.01% 459
2022
Q2 		$31.2K Buy
65
+10
+18% +$5.99K ﹤0.01% 920
2022
Q1 		$43K Hold
55
– – ﹤0.01% 499
2021
Q4 		$43K Buy
55
+5
+10% +$4.26K ﹤0.01% 516
2021
Q3 		$46K Buy
+50
New +$48.4K ﹤0.01% 503

Other funds holding PPBT

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
TWC
TD Waterhouse Canada Toronto, Ontario, Canada $38B AUM 39.14% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
GRP
Global Retirement Partners San Rafael, California $5.64B AUM
NSIM
North Star Investment Management Chicago, Illinois $1.84B AUM 28.81% 1-Year Est. Return

Venture Visionary Partners's PPBT Position: Q3 2024 in Review

Venture Visionary Partners sold out of Purple Biotech (PPBT) in Q3 2024, closing a stake of 111 shares — an estimated $9.02K sold.

Venture Visionary Partners first reported a position in PPBT in Q3 2021 and held it in 12 quarters. The position peaked at $46K in Q3 2021. 10 funds tracked by Wall St. Rank hold PPBT as of Q3 2024.

  • Venture Visionary Partners reported no remaining Purple Biotech position as of Q3 2024 after selling out during the quarter.
  • Venture Visionary Partners sold 111 Purple Biotech shares in Q3 2024, an estimated $9.02K.
  • Venture Visionary Partners first reported a position in Purple Biotech in Q3 2021 and held it in 12 quarters.
  • Venture Visionary Partners's Purple Biotech position peaked at $46K in Q3 2021.
  • 10 funds tracked by Wall St. Rank held Purple Biotech as of Q3 2024.

Based on Venture Visionary Partners's 13F filing for Q3 2024, filed 21 Oct 2024.